30 July 2019 - Deborah Wilkes
Premium
Pfizer has announced plans to merge its off-patent pharmaceutical business Upjohn with generics company Mylan. The deal includes Mylan's OTC products with sales in excess of USD1 billion.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.